The Paneth cells could become a target for treatments, according to researchers from the University of Cambridge and Harvard University. The discovery of the role they play in intestinal inflammation could open the door for an entirely new approach to Crohn’s disease therapies.
More Articles on Gastroenterology:
RedHill Biopharma Seeks Patients for Phase III Crohn’s Disease Treatment Drug Trial
Kanawha Valley Gastroenterology Associates Selects Benchmark Systems EHR
Dr. Gurpreet Singh Joins Woodland Healthcare in California
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
